European Archives - Page 8 of 1139 - European Medical Journal

ESPID 2025: Expanded Antibiotic Policy Reduces Severe Group A Streptococcal Infections

This is the first real-world evidence that expanded prophylactic antibiotic use can reduce community transmission of iGAS.

Machine Learning Model Predicts COPD Exacerbations Using Digital Inhaler Data

Machine learning models using data from digital inhalers can successfully predict COPD exacerbations up to 5 days in advance.

Impaired IgA Immunity Predicts Bronchiolitis Obliterans Syndrome After Lung Transplant

New research suggests that early impairment in mucosal IgA immunity may contribute to the later development of bronchiolitis obliterans syndrome in lung transplant recipients.

ESPID 2025: Maternal RSV Vaccine Cuts Infant Admissions in Argentina

Preliminary surveillance data from Argentina’s national maternal RSV vaccination programme show a marked reduction in infant hospitalisations during the 2024 RSV season.

Inhaled Microplastics Linked to Cardiovascular Disease Risk

Once inhaled or ingested, these plastics can lodge in human tissues, including the lungs, blood, and even vascular tissues.

Navigating treatment switch in LOPD

This symposium, ‘A case-based approach to navigating treatment switch in late-onset Pompe Disease (LOPD)’, was held at the 21st…

Blood Test Reveals Early Biomarkers for Teen Depression

Blood test identifies unique microRNA markers for adolescent depression, paving the way for earlier, objective diagnosis.

Advances in 2L ER+/HER2− mBC therapy

Despite advances in first-line endocrine therapy (ET) plus cyclin-dependent 4/6 kinase inhibitors (CDK4/6i) in oestrogen receptor-positive…

EMJ Oncology 13 [Supplement 2] 2025

A review of the latest strategies for managing oestrogen therapy resistance in ER+/HER2− metastatic breast cancer, focusing on biomarker…

ESPID 2025: Cell-Based Influenza Vaccine Offers Better Protection in Children

New data from a large paediatric cohort suggest that cell-based influenza vaccines provide improved protection over egg-based formulations.